Larvol Delta - Study-to-Evaluate-Safety-and-Pharmacokinetics-of-BIVIGAM174-in-Primary-Immune-Deficiency-Subjects-Aged-2-to-16

Bivigam (immune globulin intravenous [human]) - ADMA Biologics

http://clinicaltrials.gov/ct2/show/NCT03164967

Sep 14, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next